| abstract |
This application uses 2-phenylbenzofuran derivative compounds and compositions, and compounds and compositions as disclosed herein, to treat ophthalmic diseases, neurological disorders and protein aggregation related disorders in patients. A method is disclosed. Further provided herein is a method of treating an eye disease in a patient in need of treating the eye disease, comprising administering to the patient a therapeutically effective amount of a compound of formula I as described above. Is described. The eye disease can be selected from the group consisting of macular degeneration, retinitis pigmentosa, retinopathy, glaucoma and cataract. |